Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mass Drug Administration and Targeted Control Against Carriage to Reduce Plasmodium Transmission in the Sahel - Administration de Masse d'Antipaludiques et Lutte ciblée Contre le Portage Pour REduire la Transmission de Plasmodium au Sahel

NCT07281443 is registered in ClinicalTrials.gov with Institut de Recherche pour le Developpement as lead sponsor.

NCT NCT07281443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07281443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mass Drug Administration and Targeted Control Against Carriage to Reduce Plasmodium Transmission in the Sahel - Administration de Masse d'Antipaludiques et Lutte ciblée Contre le Portage Pour REduire la Transmission de Plasmodium au Sahel
Lead sponsor
Institut de Recherche pour le Developpement
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 23, 2024
Completion date
December 31, 2027
Enrollment
18,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, asymptomatic parasitaemia, malaria, falciparum